Document Detail

Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications.
MedLine Citation:
PMID:  9532988     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To determine whether prophylactic, low dose controlled-release aspirin improves outcome for pregnant women and their babies in Barbados. DESIGN: Randomised placebo-controlled trial. SETTING: The Queen Elizabeth Hospital, Barbados. POPULATION: All women attending antenatal clinics between 12 and 32 weeks of gestation were eligible, if without specific contraindications to aspirin and unlikely to deliver immediately. METHODS: Randomisation was computer-generated in the antenatal clinic; 1822 women were allocated to receive 75 mg controlled-release aspirin and 1825 matching placebo. MAIN OUTCOME MEASURES: Proteinuric pre-eclampsia, other pregnancy-induced hypertension, pregnancy duration, birthweight, stillbirths and neonatal deaths, major neonatal events. RESULTS: All but three women from each group were followed up successfully. Forty-four percent were primigravid, and 8% had previous obstetric complications. There were no significant differences between the allocated treatment groups in the incidence of proteinuric pre-eclampsia (40 [2.2%] of those allocated aspirin, compared with 46 [2.5%] allocated placebo), of preterm delivery (255 [14.0%] vs 270 [14.8%]), of birthweight < 1500 g (32 [1.7%] vs 33 [1.8%]) or of stillbirth and neonatal death (44 [2.4%] vs 38 [2.1%]). Aspirin was not associated with excess risk of maternal or fetal bleeding. CONCLUSIONS: The results of this study in Barbados do not support the routine use of low dose aspirin for prevention of pre-eclampsia or its complications, confirming results of previous large trials in other settings.
The effect of administration of a prophylactic dose of controlled-release aspirin on the prevention of pre-eclampsia was investigated in a randomized placebo-controlled trial conducted at the Queen Elizabeth Hospital in Barbados in 1992-94. All women attending hospital antenatal clinics between 12 and 32 weeks of gestation were eligible for the study; enrolled were 1822 cases allocated to receive 75 mg of aspirin per day and 1825 matched controls who received a placebo. Study participants represented about 60% of women who gave birth during the enrollment period. Aspirin administration was not associated with any excessive risk of infant or maternal bleeding. However, there were no significant differences between cases and controls in terms of the incidence of proteinuric pre-eclampsia (2.2% vs. 2.5%), preterm delivery (14.0% vs. 14.8%), birth weight under 1500 g (1.7% vs. 1.8%), or stillbirth and neonatal death (2.4% vs. 2.1%). These results were not affected by the time of pregnancy at which aspirin prophylaxis was initiated or parity. The Barbados findings are consistent with previous studies and fail to support the routine use of low-dose aspirin for the prevention of pre-eclampsia and its complications.
Y E Rotchell; J K Cruickshank; M P Gay; J Griffiths; A Stewart; B Farrell; S Ayers; A Hennis; A Grant; L Duley; R Collins
Related Documents :
15521878 - Adverse maternal outcomes in multifetal pregnancies.
9352768 - Perioperative management of intra-partum seizure.
3605078 - Essential thrombocythemia associated with recurrent abortions and fetal growth retardat...
2264408 - Increased placental phospholipase a2 activities in pre-eclampsia.
23288908 - Targeted nanoparticle delivery of doxorubicin into placental tissues to treat ectopic p...
2199588 - Prediction of implantation by the sonographic appearance of the endometrium during cont...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  British journal of obstetrics and gynaecology     Volume:  105     ISSN:  0306-5456     ISO Abbreviation:  Br J Obstet Gynaecol     Publication Date:  1998 Mar 
Date Detail:
Created Date:  1998-04-24     Completed Date:  1998-04-24     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7503752     Medline TA:  Br J Obstet Gynaecol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  286-92     Citation Subset:  AIM; IM; J    
Faculty of Medical Sciences, University of the West Indies, Queen Elizabeth Hospital, Barbados.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aspirin / administration & dosage*
Barbados / epidemiology
Birth Weight
Delayed-Action Preparations
Fetal Death
Gestational Age
Infant Mortality
Infant, Newborn
Platelet Aggregation Inhibitors / administration & dosage*
Pre-Eclampsia / prevention & control*
Pregnancy Outcome
Prenatal Care
Time Factors
Reg. No./Substance:
0/Delayed-Action Preparations; 0/Platelet Aggregation Inhibitors; 50-78-2/Aspirin
Comment In:
Br J Obstet Gynaecol. 1999 Feb;106(2):180   [PMID:  10426687 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A randomised trial of mode of delivery in women infected with the human immunodeficiency virus.
Next Document:  A randomised trial of low dose aspirin for primiparae in pregnancy. The Jamaica Low Dose Aspirin Stu...